Why investors love China's loss-making health startups

No profit, no problem: a string of Chinese healthcare firms are riding momentum from strong policy support and a vast consumer market all the way to IPOs. But it's not too late to find a good deal.

Why would scores of investors from across the world want to pile into loss-making companies in a sector that is at the mercy of China's notoriously unpredictable regulators? There are 1.3 billion good reasons.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media